Bond Bristol Myers Squibb 4.55% ( USU11009AW45 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||||
| Market price | |||||||||||
| Country | United States
|
||||||||||
| ISIN code |
USU11009AW45 ( in USD )
|
||||||||||
| Interest rate | 4.55% per year ( payment 2 times a year) | ||||||||||
| Maturity | 20/02/2048 | ||||||||||
|
Prospectus brochure in PDF format |
|||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 1 456 840 000 USD | ||||||||||
| Cusip | U11009AW4 | ||||||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 20/02/2027 ( In 177 days ) | ||||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code USU11009AW45, pays a coupon of 4.55% per year. The coupons are paid 2 times per year and the Bond maturity is 20/02/2048 The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code USU11009AW45, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||
| |||||||||||
Français
Italiano
United States